1 results match your criteria: "Hospital Universitario Ramon y Cajal (IRYCIS) and CIBERESP; alvsanmillan@gmail.com.[Affiliation]"
Mammographic density and breast cancer in women from high risk families.
Breast Cancer Res
July 2015
National Center for Epidemiology, Carlos III Institute of Health, Monforte de Lemos 5, 28029, Madrid, Spain.
Introduction: Mammographic density (MD) is one of the strongest determinants of sporadic breast cancer (BC). In this study, we compared MD in BRCA1/2 mutation carriers and non-carriers from BRCA1/2 mutation-positive families and investigated the association between MD and BC among BRCA1/2 mutation carriers per type of mutation and tumor subtype.
Methods: The study was carried out in 1039 female members of BRCA1 and BRCA2 mutation-positive families followed at 16 Spanish Genetic Counseling Units.